Stockreport

Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives

Tevogen Bio Holdings Inc.  (TVGN) 
PDF Supports expansion of Tevogen’s ExacTcell™ platform toward additional clinical trialsBolsters a financial path to positive cashflow and minimizes dilution WARREN, N. [Read more]